Lam Research Corporation Reports Financial Results for the Quarter Ended March 27, 2022

FREMONT, Calif., April 20, 2022 (GLOBE NEWSWIRE) — Lam Research Corporation (the “Company,” “Lam,” “Lam Research“) today announced financial results for the quarter ended March 27, 2022 (the “March 2022 quarter”).

Highlights for the March 2022 quarter were as follows:

• Revenue of $4.06 billion.
• U.S. GAAP gross margin of 44.7%, U.S. GAAP operating income as a percentage of revenue of 29.4%, and U.S. GAAP diluted EPS of $7.30.
• Non-GAAP gross margin of 44.7%, non-GAAP operating income as a percentage of revenue of 29.4%, and non-GAAP diluted EPS of $7.40.

Key Financial Data for the Quarters Ended
March 27, 2022 and December 26, 2021 
(in thousands, except per-share data, percentages, and basis points) 

U.S. GAAP
		March 2022				December 2021				Change Q/Q
Revenue		$	4,060,416			$	4,226,604			– 4	%
Gross margin as percentage of revenue			44.7	%			46.8	%		– 210 bps
Operating income as percentage of revenue			29.4	%			31.7	%		– 230 bps
Diluted EPS		$	7.30			$	8.44			– 14	%
Non-GAAP
		March 2022				December 2021				Change Q/Q
Revenue		$	4,060,416			$	4,226,604			– 4	%
Gross margin as percentage of revenue			44.7	%			46.8	%		– 210 bps
Operating income as percentage of revenue			29.4	%			32.0	%		– 260 bps
Diluted EPS		$	7.40			$	8.53			– 13	%

U.S. GAAP Financial Results

For the March 2022 quarter, revenue was $4,060 million, gross margin was $1,817 million, or 44.7% of revenue, operating expenses were $625 million, operating income was 29.4% of revenue, and net income was $1,022 million, or $7.30 per diluted share on a U.S. GAAP basis. This compares to revenue of $4,227 million, gross margin of $1,978 million, or 46.8% of revenue, operating expenses of $640 million, operating income of 31.7% of revenue, and net income of $1,195 million, or $8.44 per diluted share, for the quarter ended December 26, 2021 (the “December 2021 quarter”).

Non-GAAP Financial Results

For the March 2022 quarter, non-GAAP gross margin was $1,815 million, or 44.7% of revenue, non-GAAP operating expenses were $621 million, non-GAAP operating income was 29.4% of revenue, and non-GAAP net income was $1,036 million, or $7.40 per diluted share. This compares to non-GAAP gross margin of $1,979 million, or 46.8% of revenue, non-GAAP operating expenses of $627 million, non-GAAP operating income of 32.0% of revenue, and non-GAAP net income of $1,207 million, or $8.53 per diluted share, for the December 2021 quarter.

“In an extraordinarily difficult supply environment, Lam reported March quarter results within guided ranges,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “We are focused on resolving our supply issues as quickly as possible to support strong customer demand. We remain confident in the secular drivers of wafer fabrication equipment investment as well as Lam’s leadership position and expect to return to solid growth as industry constraints ease.”

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to $4.6 billion at the end of the March 2022 quarter compared to $5.6 billion at the end of the December 2021 quarter. This decrease was primarily the result of $1.3 billion of share repurchases, including net share settlement of employee stock-based compensation; $211 million of dividends paid to stockholders; and $145 million of capital expenditures, partially offset by $758 million of cash generated from operating activities.

Deferred revenue at the end of the March 2022 quarter increased to $2,069 million compared to $1,458 million as of the end of the December 2021 quarter. Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptances. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $263 million as of March 27, 2022 and $328 million as of December 26, 2021.

Revenue

The geographic distribution of revenue during the March 2022 quarter is shown in the following table:

Region	Revenue
China	31	%
Korea	24	%
Taiwan	16	%
Japan	9	%
Southeast Asia	9	%
United States	8	%
Europe	3	%

The following table presents revenue disaggregated between system and customer support-related revenue:

	Three Months Ended
	March 27, 2022			December 26, 2021			March 28, 2021
	(In thousands)
System revenue	$	2,650,842		$	2,740,173		$	2,545,306
Customer support-related revenue and other		1,409,574			1,486,431			1,302,348
	$	4,060,416		$	4,226,604		$	3,847,654

System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.

Outlook

For the quarter ended June 26, 2022, Lam is providing the following guidance:

	U.S. GAAP								Reconciling Items				Non-GAAP
Revenue	$4.20 Billion			+/-	$300 Million					—			$4.20 Billion			+/-	$300 Million
Gross margin as a percentage of revenue		44.5%		+/-		1%			$	1	Million			44.5%		+/-		1%
Operating income as a percentage of revenue		29.2%		+/-		1%			$	11	Million			29.5%		+/-		1%
Net income per diluted share		$7.18		+/-		$0.75			$	10	Million			$7.25		+/-		$0.75
Diluted share count	139 Million									—			139 Million

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or recognized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

• Gross margin as a percentage of revenue – amortization related to intangible assets acquired through business combinations, $1 million.
• Operating income as a percentage of revenue – amortization related to intangible assets acquired through business combinations, $11 million.
• Net income per diluted share – amortization related to intangible assets acquired though business combinations, $11 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($2 million); totaling $10 million.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the March 2022 and December 2021 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax benefit of non-GAAP items.

Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at http://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; customer and industry investment and demand for wafer fabrication equipment and for our products; supply chain conditions and other industry constraints, our efforts to address them and the timing for doing so, and the impacts on our results; and our position in the industry and prospects for growth. Some factors that may affect these forward-looking statements include: supply chain disruptions have limited and are expected to continue to limit our ability to meet demand for our products; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 27, 2021 and our quarterly report on Form 10-Q for the fiscal quarter ended December 26, 2021. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam’s equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)

Consolidated Financial Tables Follow.

 ###

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited) 

	Three Months Ended												Nine Months Ended
	March 27, 2022				December 26, 2021				March 28, 2021				March 27, 2022				March 28, 2021
Revenue	$	4,060,416			$	4,226,604			$	3,847,654			$	12,591,485			$	10,480,971
Cost of goods sold		2,243,791				2,248,688				2,067,523				6,820,190				5,590,866
Gross margin		1,816,625				1,977,916				1,780,131				5,771,295				4,890,105
Gross margin as a percent of revenue		44.7	%			46.8	%			46.3	%			45.8	%			46.7	%
Research and development		407,120				403,644				381,120				1,193,091				1,111,659
Selling, general and administrative		217,408				236,133				203,703				675,735				612,350
Total operating expenses		624,528				639,777				584,823				1,868,826				1,724,009
Operating income		1,192,097				1,338,139				1,195,308				3,902,469				3,166,096
Operating income as a percent of revenue		29.4	%			31.7	%			31.1	%			31.0	%			30.2	%
Other income (expense), net		(57,402	)			17,999				(35,320	)			(68,260	)			(104,053	)
Income before income taxes		1,134,695				1,356,138				1,159,988				3,834,209				3,062,043
Income tax expense		(112,917	)			(161,308	)			(88,867	)			(437,857	)			(298,242	)
Net income	$	1,021,778			$	1,194,830			$	1,071,121			$	3,396,352			$	2,763,801
Net income per share:
Basic	$	7.34			$	8.50			$	7.51			$	24.17			$	19.20
Diluted	$	7.30			$	8.44			$	7.41			$	24.02			$	18.94
Number of shares used in per share calculations:
Basic		139,229				140,630				142,676				140,534				143,925
Diluted		140,057				141,530				144,609				141,400				145,923
Cash dividend declared per common share	$	1.50			$	1.50			$	1.30			$	4.50			$	3.90

 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)

	March 27, 2022			December 26, 2021			June 27, 2021
	(unaudited)			(unaudited)				(1)
ASSETS
Cash and cash equivalents	$	4,194,719		$	5,086,544		$	4,418,263
Investments		160,072			242,590			1,310,872
Accounts receivable, net		3,702,320			3,402,840			3,026,430
Inventories		3,479,332			3,074,177			2,689,294
Prepaid expenses and other current assets		351,658			296,711			207,528
Total current assets		11,888,101			12,102,862			11,652,387
Property and equipment, net		1,561,875			1,503,385			1,303,479
Restricted cash and investments		251,036			250,863			252,487
Goodwill and intangible assets		1,627,035			1,601,755			1,622,499
Other assets		1,260,984			1,226,563			1,061,300
Total assets	$	16,589,031		$	16,685,428		$	15,892,152
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations	$	7,689		$	6,201		$	11,349
Other current liabilities		4,187,052			3,856,950			3,516,518
Total current liabilities		4,194,741			3,863,151			3,527,867
Long-term debt and finance lease obligations		5,000,657			4,988,121			4,990,333
Income taxes payable		916,668			891,545			948,037
Other long-term liabilities		450,475			466,830			398,727
Total liabilities		10,562,541			10,209,647			9,864,964
Stockholders’ equity (2)		6,026,490			6,475,781			6,027,188
Total liabilities and stockholders’ equity	$	16,589,031		$	16,685,428		$	15,892,152

(1	)	Derived from audited financial statements.
(2	)	Common shares issued and outstanding were 138,707 as of March 27, 2022, 140,275 as of December 26, 2021, and 142,501 as of June 27, 2021.

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)

	Three Months Ended												Nine Months Ended
	March 27, 2022				December 26, 2021				March 28, 2021				March 27, 2022				March 28, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	1,021,778			$	1,194,830			$	1,071,121			$	3,396,352			$	2,763,801
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		84,228				81,705				79,453				245,807				228,754
Deferred income taxes		(56,878	)			(13,550	)			(1,136	)			(83,451	)			(5,448	)
Equity-based compensation expense		68,543				62,834				55,746				189,476				163,843
Other, net		(3,121	)			(66,514	)			(635	)			(78,325	)			10,394
Changes in operating assets and liabilities		(356,840	)			181,201				(39,469	)			(1,014,119	)			(1,009,116	)
Net cash provided by operating activities		757,710				1,440,506				1,165,080				2,655,740				2,152,228
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets		(145,368	)			(138,493	)			(89,596	)			(420,288	)			(244,474	)
Net sale (purchase) of available-for-sale securities		79,184				325,171				233,529				1,142,398				(335,443	)
Other, net		(28,380	)			(595	)			(27,997	)			(33,898	)			(35,873	)
Net cash (used for) provided by investing activities		(94,564	)			186,083				115,936				688,212				(615,790	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt		(1,821	)			(1,698	)			(16,245	)			(9,857	)			(40,014	)
Treasury stock purchases		(1,338,006	)			(414,815	)			(1,094,571	)			(2,989,574	)			(2,266,449	)
Dividends paid		(210,587	)			(211,216	)			(186,551	)			(607,234	)			(541,607	)
Reissuance of treasury stock related to employee stock purchase plan		—				46,380				—				46,380				41,434
Proceeds from issuance of common stock		492				3,451				9,626				4,685				23,272
Other, net		214				(205	)			(665	)			197				(1,844	)
Net cash used for financing activities		(1,549,708	)			(578,103	)			(1,288,406	)			(3,555,403	)			(2,785,208	)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash		(5,090	)			(4,678	)			(5,756	)			(13,544	)			6,513
Net (decrease) increase in cash, cash equivalents, and restricted cash		(891,652	)			1,043,808				(13,146	)			(224,995	)			(1,242,257	)
Cash, cash equivalents, and restricted cash at beginning of period		5,337,407				4,293,599				3,939,972				4,670,750				5,169,083
Cash, cash equivalents, and restricted cash at end of period	$	4,445,755			$	5,337,407			$	3,926,826			$	4,445,755			$	3,926,826

Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)

	Three Months Ended
	March 27, 2022				December 26, 2021
Revenue	$	4,060,416			$	4,226,604
Gross margin	$	1,814,910			$	1,979,000
Gross margin as percentage of revenue		44.7	%			46.8	%
Operating expenses	$	620,636			$	627,445
Operating income	$	1,194,274			$	1,351,555
Operating income as a percentage of revenue		29.4	%			32.0	%
Net income	$	1,036,359			$	1,207,340
Net income per diluted share	$	7.40			$	8.53
Shares used in per share calculation – diluted		140,057				141,530

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 

	Three Months Ended
	March 27, 2022				December 26, 2021
U.S. GAAP net income	$	1,021,778			$	1,194,830
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations – cost of goods sold		1,153				1,092
Elective deferred compensation (“EDC”) related liability valuation decrease – cost of goods sold		(2,868	)			(8	)
EDC related liability valuation decrease – research and development		(5,161	)			(15	)
Amortization related to intangible assets acquired through certain business combinations – selling, general and administrative		12,494				12,357
EDC related liability valuation decrease – selling, general and administrative		(3,441	)			(10	)
Amortization of note discounts – other income (expense), net		695				689
Loss on EDC related asset – other income (expense), net		13,118				56
Net income tax benefit on non-GAAP items		(1,409	)			(1,651	)
Non-GAAP net income	$	1,036,359			$	1,207,340
Non-GAAP net income per diluted share	$	7.40			$	8.53
U.S. GAAP net income per diluted share	$	7.30			$	8.44
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation		140,057				141,530

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited) 

	Three Months Ended
	March 27, 2022				December 26, 2021
U.S. GAAP gross margin	$	1,816,625			$	1,977,916
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations		1,153				1,092
EDC related liability valuation decrease		(2,868	)			(8	)
Non-GAAP gross margin	$	1,814,910			$	1,979,000
U.S. GAAP gross margin as a percentage of revenue		44.7	%			46.8	%
Non-GAAP gross margin as a percentage of revenue		44.7	%			46.8	%
U.S. GAAP operating expenses	$	624,528			$	639,777
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations		(12,494	)			(12,357	)
EDC related liability valuation decrease		8,602				25
Non-GAAP operating expenses	$	620,636			$	627,445
U.S. GAAP operating income	$	1,192,097			$	1,338,139
Non-GAAP operating income	$	1,194,274			$	1,351,555
U.S. GAAP operating income as percent of revenue		29.4	%			31.7	%
Non-GAAP operating income as a percent of revenue		29.4	%			32.0	%

Lam Research Corporation Contacts:

Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: [email protected]

Source: Lam Research Corporation###

Source: Lam Research Corporation